| Literature DB >> 1934281 |
Y Habraken1, C A Carter, M Sekiguchi, D B Ludlum.
Abstract
3-Methyladenine DNA glycosylase II (Gly II), purified from Escherichia coli cells which carry the plasmid PYN1000, has been tested for its ability to release N2,3-ethanoguanine from DNA modified by the antitumor agent N-[2-chloroethyl-1,2-14C]-N'-cyclohexyl-N-nitrosourea ([14C]CCNU). Gly II has been shown to release N2,3-ethanoguanine in a protein- and time-dependent manner at a rate that exceeds the rate at which this enzyme releases other alkylated bases from [14C]CCNU-modified DNA. This finding widens the known substrate specificity for Gly II to include a modified base which bears an exocyclic ring structure, a class of modifications caused by a variety of chemical carcinogens.Entities:
Mesh:
Substances:
Year: 1991 PMID: 1934281 DOI: 10.1093/carcin/12.10.1971
Source DB: PubMed Journal: Carcinogenesis ISSN: 0143-3334 Impact factor: 4.944